{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:45:56Z","timestamp":1793310356481,"version":"4.5.0"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.phrs.2024.107367","type":"journal-article","created":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T10:03:13Z","timestamp":1724580193000},"page":"107367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Metformin: From diabetes to cancer to prolongation of life"],"prefix":"10.1016","volume":"208","author":[{"given":"Cesare R.","family":"Sirtori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107367_bib1","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1039\/CT9222101790","article-title":"The preparation of methylguanidine, and of \u03b2\u03b2-dimethylguanidine by the interaction of dicyanodiamide, and methylammonium and dimethylammonium chlorides respectively","volume":"121","author":"Werner","year":"1922","journal-title":"J. Chem. Soc."},{"key":"10.1016\/j.phrs.2024.107367_bib2","first-page":"1295","article-title":"Du nouveau dans les antidiab\u00e9tiques. La NN dimethylamine guanyl guanide (N.N.D.G.)","volume":"36","author":"Sterne","year":"1957","journal-title":"Maroc Med."},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"issue":"Suppl 3","key":"10.1016\/j.phrs.2024.107367_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.15663","article-title":"Metformin: Therapeutic profile in the treatment of type 2 diabetes","volume":"26","author":"Bailey","year":"2024","journal-title":"Diabetes Obes. Metab."},{"issue":"11","key":"10.1016\/j.phrs.2024.107367_bib6","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa332","article-title":"Metformin biodistribution: a key to mechanisms of action?","volume":"105","author":"Sundelin","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105363","article-title":"Metformin inhibits digestive proteases and impairs protein digestion in mice","volume":"299","author":"Kelly","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.120.000219","article-title":"Targeting enteropeptidase with reversible covalent inhibitors to achieve metabolic benefits","volume":"375","author":"Sun","year":"2020","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2024.107367_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105337","article-title":"Enteropeptidase inhibition improves obesity by modulating gut microbiota composition and enterobacterial metabolites in diet-induced obese mice","volume":"163","author":"Sugama","year":"2021","journal-title":"Pharm. Res"},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib10","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/bcp.14320","article-title":"Metformin disposition-A 40-year-old mystery","volume":"86","author":"Tucker","year":"2020","journal-title":"Br. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/cpt1978246683","article-title":"Disposition of metformin (N,N-dimethylbiguanide) in man","volume":"24","author":"Sirtori","year":"1978","journal-title":"Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.1981.tb01206.x","article-title":"Metformin kinetics in healthy subjects and in patients with diabetes mellitus","volume":"12","author":"Tucker","year":"1981","journal-title":"Br. J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.bjp.0706875","article-title":"Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1\/2 for the metabolism of metformin","volume":"149","author":"Choi","year":"2006","journal-title":"Br. J. Pharm."},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/FPC.0b013e32834c0010","article-title":"The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c","volume":"21","author":"Christensen","year":"2011","journal-title":"Pharm. Genom."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00228-013-1604-7","article-title":"The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects","volume":"70","author":"Ding","year":"2014","journal-title":"Eur. J. Clin. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/clpt.2014.109","article-title":"Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin","volume":"96","author":"Goswami","year":"2014","journal-title":"Clin. Pharm. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/cpt.567","article-title":"Variants in pharmacokinetic transporters and glycemic response to metformin: a metgen meta-analysis","volume":"101","author":"Dujic","year":"2017","journal-title":"Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/cpt.1082","article-title":"ITC commentary on metformin clinical drug-drug interaction study design that enables an efficacy- and safety-based dose adjustment decision","volume":"104","author":"Zamek-Gliszczynski","year":"2018","journal-title":"Clin. Pharm. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib19","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00125-017-4352-x","article-title":"The effects of metformin on gut microbiota and the immune system as research frontiers","volume":"60","author":"Pollak","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat. Med."},{"issue":"7581","key":"10.1016\/j.phrs.2024.107367_bib21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204317","article-title":"Association of metformin administration with gut microbiome dysbiosis in healthy volunteers","volume":"13","author":"Elbere","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2024.107367_bib23","article-title":"Effects of metformin on the gut microbiota: a systematic review","volume":"77","author":"Pavlo","year":"2023","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib24","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00125-019-4848-7","article-title":"Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study","volume":"62","author":"Bryrup","year":"2019","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib25","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","article-title":"Metformin and the intestine","volume":"51","author":"Bailey","year":"2008","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib26","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cmet.2017.09.019","article-title":"Metformin alters upper small intestinal microbiota that impact a glucose-SGLT1-sensing glucoregulatory pathway","volume":"27","author":"Bauer","year":"2018","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9051098","article-title":"Akkermansia muciniphila, a new generation of beneficial microbiota in modulating obesity: a systematic review","volume":"9","author":"Abuqwider","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.phrs.2024.107367_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726707","article-title":"Metformin exerts anti-inflammatory and mucus barrier protective effects by enriching akkermansia muciniphila in mice with Ulcerative colitis","volume":"12","author":"Ke","year":"2021","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib30","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1038\/s41598-024-60081-y","article-title":"Effect of metformin and metformin\/linagliptin on gut microbiota in patients with prediabetes","volume":"14","author":"Estrella","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107367_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101498","article-title":"Metformin-induced reductions in tumor growth involves modulation of the gut microbiome","volume":"61","author":"Broadfield","year":"2022","journal-title":"Mol. Metab."},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib32","article-title":"Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17\/Treg balance","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib33","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc20-2257","article-title":"Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a randomized trial","volume":"44","author":"Mueller","year":"2021","journal-title":"Diabetes Care"},{"issue":"8162","key":"10.1016\/j.phrs.2024.107367_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(80)90713-8","article-title":"Effect of discontinuation of biguanide therapy on metabolic control in maturity-onset diabetics","volume":"1","author":"Siitonen","year":"1980","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00257727","article-title":"Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: assessment by the artificial pancreas","volume":"23","author":"Gin","year":"1982","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00315441","article-title":"and A. Sjostrand, Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles","volume":"41","author":"Hermann","year":"1991","journal-title":"Eur. J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0021-9150(77)90125-3","article-title":"Treatment of hypertriglyceridemia with metformin. Effectiveness and analysis of results","volume":"26","author":"Sirtori","year":"1977","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib38","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib39","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/js.2019-00065","article-title":"Hyperinsulinemia: an early indicator of metabolic dysfunction","volume":"3","author":"Thomas","year":"2019","journal-title":"J. Endocr. Soc."},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41574-018-0013-5","article-title":"The Reaven syndrome: a tribute to a giant","volume":"14","author":"Despres","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib41","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1038\/s41598-024-54367-4","article-title":"Metabolic syndrome: a population-based study of prevalence and risk factors","volume":"14","author":"Jamali","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib42","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM","volume":"37","author":"DeFronzo","year":"1988","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib43","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diab.43.8.1066","article-title":"Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes","volume":"43","author":"Kahn","year":"1994","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s001250050780","article-title":"From receptor to transporter: insulin signalling to glucose transport","volume":"40","author":"Holman","year":"1997","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diabetes.51.1.30","article-title":"Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects","volume":"51","author":"Ciaraldi","year":"2002","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib46","doi-asserted-by":"crossref","first-page":"E427","DOI":"10.1210\/jc.2010-2060","article-title":"Action of metformin on the insulin-signaling pathway and on glucose transport in human granulosa cells","volume":"96","author":"Rice","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib47","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/JOE-18-0520","article-title":"Metformin improves ovarian insulin signaling alterations caused by fetal programming","volume":"240","author":"Heber","year":"2019","journal-title":"J. Endocrinol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/ann.34.3.217.224","article-title":"Glitazones: clinical effects and molecular mechanisms","volume":"34","author":"Stumvoll","year":"2002","journal-title":"Ann. Med"},{"key":"10.1016\/j.phrs.2024.107367_bib49","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2147\/DMSO.S423322","article-title":"Impact of fixed combination of metformin and pioglitazone on insulin resistance of patients with Type 2 diabetes: results of a randomized open-label study","volume":"16","author":"Sun","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib50","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"issue":"23","key":"10.1016\/j.phrs.2024.107367_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93936","article-title":"Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes","volume":"3","author":"Bahne","year":"2018","journal-title":"JCI Insight"},{"issue":"6707","key":"10.1016\/j.phrs.2024.107367_bib52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.adj2537","article-title":"GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans","volume":"385","author":"Kim","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107367_bib53","doi-asserted-by":"crossref","first-page":"41085","DOI":"10.1038\/srep41085","article-title":"Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway","volume":"7","author":"Ke","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107367_bib54","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.phrs.2018.12.008","article-title":"Idebenone and T2D: a new insulin-sensitizing drug for personalized therapy","volume":"139","author":"Dassano","year":"2019","journal-title":"Pharm. Res"},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib55","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/db16-0032","article-title":"11C]-Labeled metformin distribution in the liver and small intestine using dynamic positron emission tomography in mice demonstrates tissue-specific transporter dependency","volume":"65","author":"Jensen","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1464-5491.1992.tb01716.x","article-title":"The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes","volume":"9","author":"Sum","year":"1992","journal-title":"Diabet. Med"},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib57","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0006-2952(95)02243-0","article-title":"Effect of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats.","volume":"51","author":"Lenzen","year":"1996","journal-title":"Biochem Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib58","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211933120","article-title":"Metformin acts in the gut and induces gut-liver crosstalk","volume":"120","author":"Tobar","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7899","key":"10.1016\/j.phrs.2024.107367_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","article-title":"Accumulation of metformin by tissues of the normal and diabetic mouse","volume":"24","author":"Wilcock","year":"1994","journal-title":"Xenobiotica"},{"issue":"6865","key":"10.1016\/j.phrs.2024.107367_bib61","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib62","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.ijo.0803695","article-title":"Metformin and body weight","volume":"32","author":"Golay","year":"2008","journal-title":"Int J. Obes. (Lond. )"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib63","first-page":"CD004095","article-title":"Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes","volume":"2005","author":"Norris","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2024.107367_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105782","article-title":"Anti-diabetic drugs and weight loss in patients with type 2 diabetes","volume":"171","author":"Lazzaroni","year":"2021","journal-title":"Pharm. Res"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib65","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"N. Engl. J. Med"},{"issue":"23","key":"10.1016\/j.phrs.2024.107367_bib66","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/j.1550-8528.1998.tb00314.x","article-title":"Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes","volume":"6","author":"Lee","year":"1998","journal-title":"Obes. Res"},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib68","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s42255-024-01018-7","article-title":"Metformin and feeding increase levels of the appetite-suppressing metabolite Lac-Phe in humans","volume":"6","author":"Scott","year":"2024","journal-title":"Nat. Metab."},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib69","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s42255-019-0146-4","article-title":"Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss","volume":"1","author":"Day","year":"2019","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc16-1682","article-title":"Growth differentiation factor 15 as a novel biomarker for metformin","volume":"40","author":"Gerstein","year":"2017","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib71","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1464-5491.1988.tb01074.x","article-title":"The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes","volume":"5","author":"Rains","year":"1988","journal-title":"Diabet. Med"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib72","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/014107688908200213","article-title":"The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy","volume":"82","author":"Rains","year":"1989","journal-title":"J. R. Soc. Med"},{"issue":"10","key":"10.1016\/j.phrs.2024.107367_bib73","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.2337\/dc15-0658","article-title":"Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes","volume":"38","author":"Xu","year":"2015","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib74","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1161\/ATVBAHA.120.315708","article-title":"New insight into metformin-induced cholesterol-lowering effect crosstalk between glucose and Cholesterol Homeostasis via ChREBP (Carbohydrate-Responsive Element-Binding Protein)-Mediated PCSK9 (Proprotein Convertase Subtilisin\/Kexin Type 9) Regulation","volume":"41","author":"Hu","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib75","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1210\/ME.2015-1090","article-title":"New insight into metformin action: regulation of ChREBP and FOXO1 activities in endothelial cells","volume":"29","author":"Li","year":"2015","journal-title":"Mol. Endocrinol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib76","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/ATVBAHA.118.311212","article-title":"Metformin and AMP kinase activation increase expression of the sterol transporters ABCG5\/8 (ATP-Binding Cassette Transporter G5\/G8) with potential antiatherogenic consequences","volume":"38","author":"Molusky","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"37","key":"10.1016\/j.phrs.2024.107367_bib77","doi-asserted-by":"crossref","first-page":"33742","DOI":"10.1074\/jbc.M203215200","article-title":"ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase","volume":"277","author":"Shimizugawa","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib78","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jphp.13138","article-title":"AMPK-SIRT1-independent inhibition of ANGPTL3 gene expression is a potential lipid-lowering mechanism of metformin","volume":"71","author":"Lin","year":"2019","journal-title":"J. Pharm. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0021-9150(78)90043-6","article-title":"Effect of metformin on lipid metabolism in the rabbit aortic wall","volume":"30","author":"Marquie","year":"1978","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib80","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0021-9150(77)90142-3","article-title":"Metformin: an antiatherosclerotic agent modifying very low density lipoproteins in rabbits","volume":"26","author":"Sirtori","year":"1977","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib81","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","article-title":"Metformin improves mitochondrial respiratory activity through activation of AMPK","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107367_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149291","article-title":"Protective effects of metformin in the pro-inflammatory cytokine induced intestinal organoids injury model","volume":"690","author":"Hahn","year":"2024","journal-title":"Biochem Biophys. Res Commun."},{"issue":"7994","key":"10.1016\/j.phrs.2024.107367_bib83","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-023-06857-0","article-title":"Mitochondrial dysfunction abrogates dietary lipid processing in enterocytes","volume":"625","author":"Moschandrea","year":"2024","journal-title":"Nature"},{"issue":"Pt 3","key":"10.1016\/j.phrs.2024.107367_bib84","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348 Pt 3","author":"Owen","year":"2000","journal-title":"Biochem J."},{"issue":"6036","key":"10.1016\/j.phrs.2024.107367_bib85","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.1200094","article-title":"AMPK is a direct adenylate charge-regulated protein kinase","volume":"332","author":"Oakhill","year":"2011","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci. (Lond. )"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib87","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cmet.2018.09.019","article-title":"Metformin targets mitochondrial electron transport to reduce air-pollution-induced thrombosis","volume":"29","author":"Soberanes","year":"2019","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093240","article-title":"The metformin mechanism on gluconeogenesis and AMPK activation: the metabolite perspective","volume":"21","author":"Agius","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107367_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.107923","article-title":"Pollution from fine particulate matter and atherosclerosis: a narrative review","volume":"175","author":"Macchi","year":"2023","journal-title":"Environ. Int"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cmet.2014.07.013","article-title":"Control of gluconeogenesis by metformin: does redox trump energy charge?","volume":"20","author":"Baur","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107367_bib91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphar.2018.00141","article-title":"Lactate-Induced glucose output is unchanged by metformin at a therapeutic concentration - a mass spectrometry imaging study of the perfused rat liver","volume":"9","author":"Calza","year":"2018","journal-title":"Front Pharm."},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib92","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"10","key":"10.1016\/j.phrs.2024.107367_bib93","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122287119","article-title":"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis","volume":"119","author":"LaMoia","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib94","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1074\/jbc.RA118.006670","article-title":"Low metformin causes a more oxidized mitochondrial NADH\/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism","volume":"294","author":"Alshawi","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.phrs.2024.107367_bib95","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s00018-014-1598-z","article-title":"Redox regulation of endothelial cell fate","volume":"71","author":"Song","year":"2014","journal-title":"Cell Mol. Life Sci."},{"issue":"6865","key":"10.1016\/j.phrs.2024.107367_bib96","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib97","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nrm3013","article-title":"Mitochondrial fusion and fission in cell life and death","volume":"11","author":"Westermann","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib98","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2353\/ajpath.2007.060960","article-title":"Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions","volume":"170","author":"Zhang","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib99","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.freeradbiomed.2011.11.026","article-title":"The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+\/-\/ApoE-\/- mice.","volume":"52","author":"Mercer","year":"2012","journal-title":"Free Radic. Biol. Med"},{"issue":"42","key":"10.1016\/j.phrs.2024.107367_bib100","doi-asserted-by":"crossref","first-page":"43940","DOI":"10.1074\/jbc.M404421200","article-title":"Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species","volume":"279","author":"Zou","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib101","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib102","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db07-0381","article-title":"Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP","volume":"57","author":"Kim","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib103","doi-asserted-by":"crossref","first-page":"H2497","DOI":"10.1152\/ajpheart.00873.2007","article-title":"Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms","volume":"294","author":"Saeedi","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2024.107367_bib104","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1210\/me.2013-1109","article-title":"AMPK regulates ER morphology and function in stressed pancreatic beta-cells via phosphorylation of DRP1","volume":"27","author":"Wikstrom","year":"2013","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/db16-0915","article-title":"Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of Drp1-mediated mitochondrial fission","volume":"66","author":"Wang","year":"2017","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/MCB.05603-11","article-title":"Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle","volume":"32","author":"Jheng","year":"2012","journal-title":"Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107367_bib107","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.2337\/db13-0039","article-title":"C-peptide activates AMPKalpha and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes","volume":"62","author":"Bhatt","year":"2013","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib108","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/ars.2021.0019","article-title":"Does metformin modulate mitochondrial dynamics and function in type 2 diabetic patients?","volume":"35","author":"de Maranon","year":"2021","journal-title":"Antioxid. Redox Signal"},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib109","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2014.02.004","article-title":"Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart","volume":"19","author":"Dogan","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107367_bib110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceb.2015.01.002","article-title":"PINK1\/Parkin-mediated mitophagy in mammalian cells","volume":"33","author":"Eiyama","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107367_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102342","article-title":"Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients","volume":"53","author":"de Maranon","year":"2022","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib112","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1038\/s41467-023-42277-4","article-title":"Inflammatory macrophages reprogram to immunosuppression by reducing mitochondrial translation","volume":"14","author":"Cortes","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib113","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.1038\/s41467-023-42428-7","article-title":"The transcription factor Zeb1 controls homeostasis and function of type 1 conventional dendritic cells","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib114","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jphs.2024.07.004","article-title":"Y., The role of ZEB1 in mediating the protective effects of metformin on skeletal muscle atrophy","volume":"156","author":"Jia","year":"2024","journal-title":"J. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.phrs.2024.107367_bib116","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib117","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/hc0502.104540","article-title":"Fundamentals of endothelial function for the clinical cardiologist","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3565","article-title":"Inflammation and vascular dysfunction: the negative synergistic combination of diabetes and COVID-19","volume":"38","author":"Bolla","year":"2022","journal-title":"Diabetes Metab. Res Rev."},{"issue":"14","key":"10.1016\/j.phrs.2024.107367_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144928","article-title":"The impact of diabetes mellitus on cardiovascular risk onset in children and adolescents","volume":"21","author":"Pastore","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc Diabetol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib121","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/00005344-198409000-00027","article-title":"Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease","volume":"6","author":"Sirtori","year":"1984","journal-title":"J. Cardiovasc Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib122","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0735-1097(01)01129-9","article-title":"Improved endothelial function with metformin in type 2 diabetes mellitus","volume":"37","author":"Mather","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib123","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2796.2005.01531.x","article-title":"Metformin improves endothelial function in patients with metabolic syndrome","volume":"258","author":"Vitale","year":"2005","journal-title":"J. Intern Med"},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib124","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/dc05-2146","article-title":"Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance","volume":"29","author":"de Aguiar","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/joim.12128","article-title":"Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial","volume":"275","author":"de Jager","year":"2014","journal-title":"J. Intern Med"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11430-7","article-title":"Metformin improves endothelial function and reduces blood pressure in diabetic spontaneously hypertensive rats independent from glycemia control: comparison to Vildagliptin","volume":"7","author":"Hamidi Shishavan","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib127","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1152\/ajpendo.00287.2021","article-title":"Metformin improves skeletal muscle microvascular insulin resistance in metabolic syndrome","volume":"322","author":"Jahn","year":"2022","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"24","key":"10.1016\/j.phrs.2024.107367_bib128","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173160","article-title":"Endothelial lipid droplets suppress eNOS to link high fat consumption to blood pressure elevation","volume":"133","author":"Kim","year":"2023","journal-title":"J. Clin. Invest"},{"issue":"13","key":"10.1016\/j.phrs.2024.107367_bib129","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/bph.13833","article-title":"Activation of AMP-activated protein kinase by metformin ablates angiotensin II-induced endoplasmic reticulum stress and hypertension in mice in vivo","volume":"174","author":"Duan","year":"2017","journal-title":"Br. J. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib130","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400070R","article-title":"Metformin induction of heat shock factor 1 activation and the mitochondrial unfolded protein response alleviate cardiac remodeling in spontaneously hypertensive rats","volume":"38","author":"Xu","year":"2024","journal-title":"FASEB J."},{"issue":"41","key":"10.1016\/j.phrs.2024.107367_bib131","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1093\/eurheartj\/ehz203","article-title":"A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial","volume":"40","author":"Mohan","year":"2019","journal-title":"Eur. Heart J."},{"issue":"7503","key":"10.1016\/j.phrs.2024.107367_bib132","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.phrs.2024.107367_bib133","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1592\/phco.30.11.1159","article-title":"Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs","volume":"30","author":"McFarland","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.phrs.2024.107367_bib134","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev. Res (Philos. )"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib135","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study","volume":"52","author":"Hemkens","year":"2009","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib136","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00125-009-1444-2","article-title":"Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden","volume":"52","author":"Jonasson","year":"2009","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib137","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.2337\/dc14-0584","article-title":"Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial","volume":"37","author":"Tsilidis","year":"2014","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib138","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1940-6207.CAPR-13-0424","article-title":"Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders","volume":"7","author":"Gandini","year":"2014","journal-title":"Cancer Prev. Res (Philos. )"},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib140","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00125-009-1453-1","article-title":"Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group","volume":"52","author":"Colhoun","year":"2009","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052705","article-title":"Metformin and Breast Cancer: where are we now?","volume":"23","author":"Cejuela","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107367_bib142","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/srep00362","article-title":"Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells","volume":"2","author":"Song","year":"2012","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib143","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1158\/1078-0432.CCR-10-2243","article-title":"Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth","volume":"17","author":"Rocha","year":"2011","journal-title":"Clin. Cancer Res"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib144","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"issue":"8-9","key":"10.1016\/j.phrs.2024.107367_bib145","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.exger.2005.07.007","article-title":"Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2\/neu transgenic mice","volume":"40","author":"Anisimov","year":"2005","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib146","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib147","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2022.03.010","article-title":"Metformin treatment rescues CD8(+) T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD.","volume":"77","author":"Wabitsch","year":"2022","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib148","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41467-020-20723-x","article-title":"Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib149","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.phrs.2024.107367_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd7455","article-title":"Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells","volume":"7","author":"Guo","year":"2021","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib151","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression","volume":"11","author":"Finisguerra","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52957-1","article-title":"Effects of human-made resource hotspots on seasonal spatial strategies by a desert pitviper","volume":"9","author":"DeSantis","year":"2019","journal-title":"Sci. Rep."},{"issue":"7494","key":"10.1016\/j.phrs.2024.107367_bib153","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13110","article-title":"Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides","volume":"508","author":"Birsoy","year":"2014","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165214","article-title":"MATE2 expression is associated with cancer cell response to metformin","volume":"11","author":"Chowdhury","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ijc.29720","article-title":"Metformin use and survival after colorectal cancer: a population-based cohort study","volume":"138","author":"Mc Menamin","year":"2016","journal-title":"Int J. Cancer"},{"issue":"23","key":"10.1016\/j.phrs.2024.107367_bib156","doi-asserted-by":"crossref","first-page":"13012","DOI":"10.1073\/pnas.1918845117","article-title":"Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1","volume":"117","author":"Xie","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.phrs.2024.107367_bib157","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.phrs.2024.107367_bib158","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbrc.2023.07.029","article-title":"Metformin combined with glucose starvation synergistically suppress triple-negative breast cancer by enhanced unfolded protein response","volume":"675","author":"Li","year":"2023","journal-title":"Biochem Biophys. Res Commun."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib159","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jnci\/djae021","article-title":"Association of metformin use and cancer incidence: a systematic review and meta-analysis","volume":"116","author":"O'Connor","year":"2024","journal-title":"J. Natl. Cancer Inst."},{"issue":"7719","key":"10.1016\/j.phrs.2024.107367_bib160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","article-title":"Suppression of insulin feedback enhances the efficacy of PI3K inhibitors","volume":"560","author":"Hopkins","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib161","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170329","article-title":"PI3K\/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma","volume":"134","author":"Duchatel","year":"2024","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib162","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179144","article-title":"Just a spoonful of metformin helps the medicine go down","volume":"134","author":"Tzaridis","year":"2024","journal-title":"J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib163","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cmet.2023.12.007","article-title":"Human trials exploring anti-aging medicines","volume":"36","author":"Guarente","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib164","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","article-title":"Benefits of Metformin in attenuating the hallmarks of aging","volume":"32","author":"Kulkarni","year":"2020","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib165","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib166","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"Lopez-Otin","year":"2023","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phrs.2024.107367_bib167","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107367_bib168","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31268","article-title":"Metformin extends C. elegans lifespan through lysosomal pathway","volume":"6","author":"Chen","year":"2017","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.phrs.2024.107367_bib169","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/dme.13097","article-title":"Effect of metformin therapy on circulating amino acids in a randomized trial: the CAMERA study","volume":"33","author":"Preiss","year":"2016","journal-title":"Diabet. Med"},{"issue":"7795","key":"10.1016\/j.phrs.2024.107367_bib170","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib171","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12723","article-title":"Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults","volume":"17","author":"Kulkarni","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.phrs.2024.107367_bib172","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107367_bib173","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3389\/fphys.2019.00572","article-title":"Metformin monotherapy downregulates diabetes-associated inflammatory status and impacts on mortality","volume":"10","author":"Tizazu","year":"2019","journal-title":"Front Physiol."},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib174","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a therapeutic target for common pathologies","volume":"17","author":"Murphy","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4 Pt A","key":"10.1016\/j.phrs.2024.107367_bib175","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bbadis.2018.01.018","article-title":"Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: relevance in age-associated vascular dysfunction","volume":"1864","author":"Karnewar","year":"2018","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"7958","key":"10.1016\/j.phrs.2024.107367_bib176","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41586-023-05922-y","article-title":"Ageing-associated changes in transcriptional elongation influence longevity","volume":"616","author":"Debes","year":"2023","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.phrs.2024.107367_bib177","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrm.2016.93","article-title":"Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds","volume":"17","author":"Bonkowski","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib178","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","article-title":"Mitochondrial and metabolic dysfunction in ageing and age-related diseases","volume":"18","author":"Amorim","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib179","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107367_bib180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2018.01.007","article-title":"Metformin: Prevention of genomic instability and cancer: a review","volume":"827","author":"Najafi","year":"2018","journal-title":"Mutat. Res Genet Toxicol. Environ. Mutagen"},{"issue":"10","key":"10.1016\/j.phrs.2024.107367_bib181","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.18632\/aging.100397","article-title":"Genome protective effect of metformin as revealed by reduced level of constitutive DNA damage signaling","volume":"3","author":"Halicka","year":"2011","journal-title":"Aging (Albany NY)"},{"issue":"9","key":"10.1016\/j.phrs.2024.107367_bib182","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41580-018-0020-3","article-title":"Cellular and epigenetic drivers of stem cell ageing","volume":"19","author":"Ermolaeva","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib183","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cels.2022.05.002","article-title":"Diverse partial reprogramming strategies restore youthful gene expression and transiently suppress cell identity","volume":"13","author":"Roux","year":"2022","journal-title":"Cell Syst."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib184","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12765","article-title":"Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7","volume":"17","author":"Fang","year":"2018","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbrc.2018.02.191","article-title":"Deficiency of Atg6 impairs beneficial effect of metformin on intestinal stem cell aging in Drosophila","volume":"498","author":"Na","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib186","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","article-title":"Metformin restores CNS remyelination capacity by rejuvenating aged stem cells","volume":"25","author":"Neumann","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10.1016\/j.phrs.2024.107367_bib187","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600031","article-title":"Nuclear respiratory factor 1 and endurance exercise promote human telomere transcription","volume":"2","author":"Diman","year":"2016","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib188","doi-asserted-by":"crossref","first-page":"741","DOI":"10.18632\/aging.101781","article-title":"Association between antidiabetic agents use and leukocyte telomere shortening rates in patients with type 2 diabetes","volume":"11","author":"Liu","year":"2019","journal-title":"Aging (Albany NY)"},{"issue":"7742","key":"10.1016\/j.phrs.2024.107367_bib189","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","article-title":"L1 drives IFN in senescent cells and promotes age-associated inflammation","volume":"566","author":"De Cecco","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib190","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles' heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib191","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","article-title":"Senolytics improve physical function and increase lifespan in old age","volume":"24","author":"Xu","year":"2018","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib192","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cmet.2012.04.007","article-title":"TOR signaling and rapamycin influence longevity by regulating SKN-1\/Nrf and DAF-16\/FoxO","volume":"15","author":"Robida-Stubbs","year":"2012","journal-title":"Cell Metab."},{"issue":"7432","key":"10.1016\/j.phrs.2024.107367_bib193","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature11861","article-title":"mTOR is a key modulator of ageing and age-related disease","volume":"493","author":"Johnson","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib194","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/acel.12469","article-title":"Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence","volume":"15","author":"Noren Hooten","year":"2016","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10522-019-09838-x","article-title":"Metformin prevents against oxidative stress-induced senescence in human periodontal ligament cells","volume":"21","author":"Kuang","year":"2020","journal-title":"Biogerontology"},{"key":"10.1016\/j.phrs.2024.107367_bib196","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.acr.2021.02.001","article-title":"Autophagy and senescence, converging roles in pathophysiology as seen through mouse models","volume":"150","author":"Young","year":"2021","journal-title":"Adv. Cancer Res."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib197","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.advnut.2023.07.006","article-title":"The beneficial and adverse effects of autophagic response to caloric restriction and fasting","volume":"14","author":"Shabkhizan","year":"2023","journal-title":"Adv. Nutr."},{"issue":"5","key":"10.1016\/j.phrs.2024.107367_bib198","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbadis.2008.10.013","article-title":"A look inside the diabetic brain: contributors to diabetes-induced brain aging","volume":"1792","author":"Wrighten","year":"2009","journal-title":"Biochim Biophys. Acta"},{"issue":"4","key":"10.1016\/j.phrs.2024.107367_bib199","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11010-023-04771-7","article-title":"Metformin role in Parkinson's disease: a double-sword effect","volume":"479","author":"Alrouji","year":"2024","journal-title":"Mol. Cell Biochem"},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib200","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1073\/pnas.1013343108","article-title":"Non-ATG-initiated translation directed by microsatellite expansions","volume":"108","author":"Zu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6125","key":"10.1016\/j.phrs.2024.107367_bib201","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.phrs.2024.107367_bib202","doi-asserted-by":"crossref","first-page":"18591","DOI":"10.1073\/pnas.2005748117","article-title":"Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS\/FTD mice","volume":"117","author":"Zu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"33","key":"10.1016\/j.phrs.2024.107367_bib203","doi-asserted-by":"crossref","first-page":"19627","DOI":"10.1073\/pnas.2012363117","article-title":"Metformin treatment of the C9orf72 ALS\/FTD mouse: almost too good for words","volume":"117","author":"Rosbash","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105703","article-title":"eIF5 stimulates the CUG initiation of RAN translation of poly-GA dipeptide repeat protein (DPR) in C9orf72 FTLD\/ALS","volume":"300","author":"Gotoh","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2024.107367_bib205","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.phrs.2024.107367_bib206","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/humrep\/det116","article-title":"Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients","volume":"28","author":"Carvajal","year":"2013","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.phrs.2024.107367_bib207","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/2096-2924.232874","article-title":"Effect of metformin-induced stimulation on the expression of insulin receptor substrate 1 through negative regulation of P70S6k","volume":"2","author":"Ma","year":"2018","journal-title":"Reprod. Dev. Med."},{"issue":"3","key":"10.1016\/j.phrs.2024.107367_bib208","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/ijms23031264","article-title":"Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport","volume":"23","author":"Herman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107367_bib209","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1210\/clinem\/dgad465","article-title":"Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"109","author":"Melin","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.phrs.2024.107367_bib210","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2023.19869","article-title":"Early Metformin in gestational diabetes: a randomized clinical trial","volume":"330","author":"Dunne","year":"2023","journal-title":"JAMA"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T19:12:25Z","timestamp":1726773145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824003128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":210,"alternative-id":["S1043661824003128"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107367","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin: From diabetes to cancer to prolongation of life","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107367"}}